Home
Scholarly Works
Reversal of apixaban and rivaroxaban...
Conference

Reversal of apixaban and rivaroxaban anticoagulation by andexanet alfa in ANNEXA-A&R as assessed by non-tissue factor (TF)-initiated thrombin generation independent of TF pathway inhibitor (TFPI)

Authors

Lu G; Lin J; Bronson M; Crowther M; Conley PB; Curnutte JT

Volume

39

Pagination

pp. 1050-1050

Publisher

OXFORD UNIV PRESS

Publication Date

August 1, 2018

Name of conference

European-Society-of-Cardiology Congress

Conference place

Munich, GERMANY

Conference start date

August 25, 2018

Conference end date

August 29, 2018

Conference proceedings

EUROPEAN HEART JOURNAL

ISSN

0195-668X

Contact the Experts team